ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $501 | -83.1% | 3,800 | -34.5% | 0.00% | -100.0% |
Q2 2023 | $2,958 | -19.0% | 5,800 | 0.0% | 0.00% | -50.0% |
Q1 2023 | $3,654 | -2.9% | 5,800 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $3,765 | -62.4% | 5,800 | 0.0% | 0.00% | -66.7% |
Q3 2022 | $10,000 | +42.9% | 5,800 | 0.0% | 0.01% | +50.0% |
Q2 2022 | $7,000 | +75.0% | 5,800 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $4,000 | -33.3% | 5,800 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $6,000 | -45.5% | 5,800 | 0.0% | 0.00% | -57.1% |
Q3 2021 | $11,000 | -26.7% | 5,800 | 0.0% | 0.01% | -22.2% |
Q2 2021 | $15,000 | -28.6% | 5,800 | 0.0% | 0.01% | -40.0% |
Q1 2021 | $21,000 | +40.0% | 5,800 | 0.0% | 0.02% | +25.0% |
Q4 2020 | $15,000 | 0.0% | 5,800 | 0.0% | 0.01% | -20.0% |
Q3 2020 | $15,000 | – | 5,800 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |